Tower Research Capital (TRC)’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-55
| Closed | – | – | 5339 |
|
|
2020
Q2 | $0 | Sell |
55
-590
| -91% | – | ﹤0.01% | 5160 |
|
|
2020
Q1 | $1K | Buy |
+645
| New | +$1K | ﹤0.01% | 2931 |
|
|
2019
Q4 | – | Sell |
-2,672
| Closed | -$14K | – | 4805 |
|
|
2019
Q3 | $14K | Buy |
2,672
+1,616
| +153% | +$8.47K | ﹤0.01% | 2748 |
|
|
2019
Q2 | $10K | Buy |
+1,056
| New | +$10K | ﹤0.01% | 2590 |
|
|
2019
Q1 | – | Sell |
-467
| Closed | -$10K | – | 4606 |
|
|
2018
Q4 | $10K | Sell |
467
-198
| -30% | -$4.24K | ﹤0.01% | 2498 |
|
|
2018
Q3 | $37K | Buy |
+665
| New | +$37K | ﹤0.01% | 1956 |
|
|
2017
Q4 | – | Sell |
-172
| Closed | -$23K | – | 4393 |
|
|
2017
Q3 | $23K | Buy |
+172
| New | +$23K | ﹤0.01% | 2661 |
|
|
2016
Q1 | – | Sell |
-12
| Closed | -$2K | – | 5299 |
|
|
2015
Q4 | $2K | Sell |
12
-409
| -97% | -$68.2K | ﹤0.01% | 3884 |
|
|
2015
Q3 | $63K | Buy |
421
+411
| +4,110% | +$61.5K | 0.01% | 865 |
|
|
2015
Q2 | $10K | Sell |
10
-59
| -86% | -$59K | ﹤0.01% | 2736 |
|
|
2015
Q1 | $51K | Buy |
69
+66
| +2,200% | +$48.8K | 0.01% | 1460 |
|
|
2014
Q4 | $2K | Buy |
+3
| New | +$2K | ﹤0.01% | 3446 |
|
|
2014
Q2 | – | Sell |
-22
| Closed | -$5K | – | 4929 |
|
|
2014
Q1 | $5K | Sell |
22
-12
| -35% | -$2.73K | ﹤0.01% | 3327 |
|
|
2013
Q4 | $9K | Sell |
34
-224
| -87% | -$59.3K | ﹤0.01% | 3124 |
|
|
2013
Q3 | $59K | Sell |
258
-419
| -62% | -$95.8K | 0.01% | 1770 |
|
|
2013
Q2 | $96K | Buy |
+677
| New | +$96K | 0.01% | 525 |
|